BioCentury
ARTICLE | Company News

Binex, MaxCyte deal

December 10, 2007 8:00 AM UTC

The companies will evaluate MaxCyte's cell-loading technology for manufacturing Binex's cell-based cancer immunotherapies. Binex, which is funding the work, has two dendritic cell immunotherapies unde...